Biotricity, Inc. announced that it has entered into a securities purchase agreement to issue 55 shares of Series B Preferred Stock at a price of $9,090.91 per share for the gross proceeds of $500,000.05 on June 21, 2024. The shares will have a coupon rate of 8% and will be convertible at a conversion price of $3.50. The transaction included participation from returning investor, Ionic Ventures, LLC.